IAS
PFE icon

Integrity Advisory Solutions’s Pfizer PFE Stock Holding History

Integrity Advisory Solutions’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Sell
11,808
-265
-2% -$6.93K 0.03% 278
2026
Q1 		$339K Buy
12,073
+3,361
+39% +$89.5K 0.04% 187
2025
Q4 		$217K Buy
+8,712
New +$220K 0.03% 227

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Integrity Advisory Solutions's PFE Position: Q2 2026 in Review

Integrity Advisory Solutions reduced its Pfizer (PFE) stake by 2.2% in Q2 2026, selling an estimated $6.93K and leaving 11,808 shares worth $284K. The position accounts for 0.03% of the portfolio, ranked #278.

Integrity Advisory Solutions first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $339K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Integrity Advisory Solutions held 11,808 shares of Pfizer worth $284K as of Q2 2026.
  • Integrity Advisory Solutions sold 265 Pfizer shares in Q2 2026, an estimated $6.93K.
  • Pfizer made up 0.03% of Integrity Advisory Solutions's portfolio in Q2 2026, its #278 holding.
  • Integrity Advisory Solutions first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Integrity Advisory Solutions's Pfizer position peaked at $339K in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Integrity Advisory Solutions's 13F filing for Q2 2026, filed 31 Jul 2026.